SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001047469-14-001027
Filing Date
2014-02-19
Accepted
2014-02-19 13:06:25
Documents
3

Document Format Files

Seq Description Document Type Size
1 FINAL PROSPECTUS SUPPLEMENT a2218403z424b5.htm 424B5 390343
2 G191778.JPG g191778.jpg GRAPHIC 7061
3 G399864.JPG g399864.jpg GRAPHIC 14555
  Complete submission text file 0001047469-14-001027.txt   421934
Mailing Address LICHTSTRASSE 35 BASEL V8 CH 4056
Business Address LICHTSTRASSE 35 BASEL V8 CH 4056 01141613241111
NOVARTIS AG (Filer) CIK: 0001114448 (see all company filings)

IRS No.: 000000000 | State of Incorp.: V8 | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-183955 | Film No.: 14624883
SIC: 2834 Pharmaceutical Preparations

Mailing Address 608 FIFTH AVENUE NEW YORK NY 10020
Business Address 608 FIFTH AVENUE NEW YORK NY 10020 (212)307 1122
Novartis Capital CORP (Filer) CIK: 0001443411 (see all company filings)

IRS No.: 263086456 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-183955-02 | Film No.: 14624884
SIC: 2834 Pharmaceutical Preparations